Fact CheckerSign in

NCT07103421Completed

Impact of Non Surgical Periodontal Therapy on Cystatin C Levels

Effect of Non-Surgical Periodontal Therapy on Cystatin C Levels in Healthy and Renal Impaired Patients

Source: ClinicalTrials.gov · Last updated 5 Aug 2025

Brief summary (registry, in English)

Study the effect of non-surgical periodontal therapy on cystatin C levels in gingival crevicular fluid and serum in both healthy patients and patients with renal impairment. The number of participants is 30 individuals, divided into three groups receiving conservative periodontal treatment (scaling and root planing):Systemically and periodontally healthy patients, Patients with periodontitis without systemic diseases, and Patients with periodontitis and chronic kidney disease. The study also aims to determine the relationship between the severity of periodontal disease and kidney function by measuring cystatin C levels, which is an important biomarker for both conditions. Additionally, it seeks to assess whether non-surgical periodontal therapy can be included in the treatment protocols for kidney patients to improve their quality of life.

Status (registry)
Completed
Study type
Interventional
Enrollment
30 (actual)
First submitted
24 Jul 2025
Start date
12 May 2023
Primary completion date
10 Jun 2024
Lead sponsor
Latakia University
NCT number
NCT07103421

What you commit to

  • Study type: Interventional
  • Participants enrolled: 30
  • From 12 May 2023 to the primary completion date, 10 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Grade C periodontal disease.
  • Furcation involvement due to periodontal disease.
  • Tooth loss due to periodontal disease.

Other

  • \- Stage III or IV periodontitis.
  • Bone loss in more than 10 sites.
  • Pathological tooth mobility (Grade II or III).
  • Heavy smoking (\>10 cigarettes/day).
  • Pregnancy or lactation.
  • Patients undergoing dialysis.

Who the study is looking for

  • Patients with Stage II (Grade A or B) periodontitis (according to AAP 2017 classification).
  • Age range: 20 to 70 years.
  • No pathological tooth mobility.
  • No furcation involvement caused by periodontal disease.
  • No systemic diseases affecting periodontal or renal health.
  • No systemic antibiotic use within the previous 3 months.
  • No periodontal treatment within the previous 6 months
    • For Chronic Kidney Disease (CKD) Patients:
  • Confirmed CKD diagnosis for at least 3 years (by a consultant nephrologist).
  • Receiving conservative management (pre-dialysis).

Age in the registry: 20 years to 70 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tishreen University - faculty of Dentistry
Coordinator of this site? Confirm its status
LatakiaSyriaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.